This company is no longer active
Vallon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Vallon Pharmaceuticals has a total shareholder equity of $2.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.2M and $1.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$3.78m |
Equity | US$2.34m |
Total liabilities | US$1.81m |
Total assets | US$4.15m |
Financial Position Analysis
Short Term Liabilities: VLON's short term assets ($4.2M) exceed its short term liabilities ($1.8M).
Long Term Liabilities: VLON has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: VLON is debt free.
Reducing Debt: VLON had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VLON has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: VLON has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.5% each year